Tetra-O-Methyl Nordihydroguaiaretic Acid
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tetra-O-Methyl Nordihydroguaiaretic Acid, covering 2015-08-11 to 2015-08-11. Get the full timeline:
Most recent: Clinical Trial Update: Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma [Phase 1, Phase 2]